4YC2 image
Deposition Date 2015-02-19
Release Date 2016-03-02
Last Version Date 2024-11-06
Entry Detail
PDB ID:
4YC2
Title:
Crystal structure of the stabilized inner domain of clade A/E HIV-1 gp120 from E. coli in complex with the antibody A32.
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.02 Å
R-Value Free:
0.28
R-Value Work:
0.22
R-Value Observed:
0.23
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:The stabilized inner domain of clade A/E HIV-1 gp120 from E. coli
Mutations:V65C, S115C
Chain IDs:A (auth: G), D (auth: A)
Chain Length:156
Number of Molecules:2
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:The antibody A32 Fab heavy chain.
Chain IDs:B (auth: H), E (auth: B)
Chain Length:224
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:The antibody A32 Fab light chain.
Chain IDs:C (auth: L), F (auth: C)
Chain Length:210
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region.
Structure 24 697 709 (2016)
PMID: 27041594 DOI: 10.1016/j.str.2016.03.005

Abstact

Evidence supports a role of antibody-dependent cellular cytotoxicity (ADCC) toward transitional epitopes in the first and second constant (C1-C2) regions of gp120 (A32-like epitopes) in preventing HIV-1 infection and in vaccine-induced protection. Here, we describe the first successful attempt at isolating the inner domain (ID) of gp120 as an independent molecule that encapsulates the A32-like region within a minimal structural unit of the HIV-1 Env. Through structure-based design, we developed ID2, which consists of the ID expressed independently of the outer domain and stabilized in the CD4-bound conformation by an inter-layer disulfide bond. ID2 expresses C1-C2 epitopes in the context of CD4-triggered full-length gp120 but without any known neutralizing epitope present. Thus, ID2 represents a novel probe for the analysis and/or selective induction of antibody responses to the A32 epitope region. We also present the crystal structure of ID2 complexed with mAb A32, which defines its epitope.

Legend

Protein

Chemical

Disease

Primary Citation of related structures